Khanya Ekhaya: A Home-Based Intervention
Launched by UNIVERSITY OF MARYLAND, COLLEGE PARK · May 14, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The Khanya Ekhaya trial is studying a new way to support people living with HIV, especially focusing on their mental health. Many individuals with HIV also experience issues like depression, anxiety, and harmful drinking, which can make it hard for them to keep up with their treatment. This trial aims to see if community health workers (CHWs)—people who provide care and support in the community—can help by offering mental health support right at home. This approach is important because it goes beyond just seeing patients in a clinic, addressing mental health needs that are often overlooked.
To participate in the trial, patients must be at least 18 years old, have recently started or restarted their HIV treatment, and show signs of depression or harmful alcohol use. Community health workers involved in the study need to be at least 18 years old and must conduct home visits for patients with HIV. Participants can expect to receive support aimed at improving their mental health and helping them stay engaged in their HIV care. This trial is not yet recruiting participants, but it represents an exciting step toward integrating mental health support into the care of people living with chronic conditions like HIV.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- CHWs:
- • at least 18 years old
- • must conduct home visits for people with HIV newly initiating or re-initiating ART at the approved clinic site
- PATIENTS:
- • at least 18 years old
- • seen by a CHW after newly initiating or re-initiating ART in the past three months
- • screen positive for depressive symptoms or harmful alcohol use
- Exclusion Criteria:
- CHWs:
- • -Unable or unwilling to complete informed consent and study procedures in English, isiXhosa, or Afrikaans
- PATIENTS:
- • -Unable or unwilling to complete informed consent and study procedures in English, isiXhosa, or Afrikaans
About University Of Maryland, College Park
The University of Maryland, College Park, is a leading research institution dedicated to advancing knowledge and innovation in various fields, including health and medicine. As a prominent clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and commitment to rigorous scientific inquiry to facilitate impactful clinical research. The institution fosters collaborations among faculty, healthcare professionals, and industry partners to enhance patient care and drive advancements in medical science, ensuring compliance with ethical standards and regulatory requirements throughout the research process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cape Town, Western Cape, South Africa
Patients applied
Trial Officials
Jessica F Magidson, PhD
Principal Investigator
University of Maryland, College Park
Tara Carney, PhD
Principal Investigator
Medical Research Council, South Africa
Bronwyn Myers, PhD
Principal Investigator
Curtin University; South African Medical Research Council
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported